Mostrando 2 resultados de: 2
Filtros aplicados
Área temáticas
Enfermedades(2)
Farmacología y terapéutica(2)
Problemas sociales y servicios a grupos(2)
Área de conocimiento
Neurología(2)
Año de Publicación
2021(2)
Origen
scopus(2)
Coronavirus disease 2019 in Latin American patients with multiple sclerosis
OtherAbstract: Patients with multiple sclerosis (MS) who present coronavirus disease 2019 (COVID-19) are of particuPalabras claves:covid-19, Multiple Sclerosis, ocrelizumab, pandemic, rituximabAutores:Carcamo Rodriguez C., Carmisciano L., Ciampi E., Edgar Patricio Correa, Fragoso Y.D., Gomes S., Pimentel M.L.V., Ponzano M., Santos G.A.C., Schiavetti I., Sormani M.P., Steinberg J., Treviño-Frenk I., Vecino M.C.A., Vrech C., Winckler T.C.A.Fuentes:scopusImpact of Rituximab on relapse rate and disability in an Ecuadorian cohort of patients with neuromyelitis optica spectrum disorders
ArticleAbstract: Background: Neuromyelitis Optica Spectrum Disorder (NMOSD) is a severe inflammatory demyelinating diPalabras claves:anti-CD20 monoclonal antibody, B-cells, Ecuadorian NMOSD patients, neuromyelitis optica spectrum disorders, rituximabAutores:Edgar Patricio Correa, Francisco José Caiza-Zambrano, Miño-Zambrano J.E., Torres-Herrán G.E., Víctor P.G.Fuentes:scopus